{"id":79214,"date":"2026-05-10T16:15:11","date_gmt":"2026-05-10T16:15:11","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/79214\/"},"modified":"2026-05-10T16:15:11","modified_gmt":"2026-05-10T16:15:11","slug":"novo-nordisk-ceo-discusses-oral-weight-loss-drugs-amazon-same-day-delivery-and-drug-pricing-news-and-statistics","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/79214\/","title":{"rendered":"Novo Nordisk CEO Discusses Oral Weight-Loss Drugs, Amazon Same-Day Delivery, and Drug Pricing &#8211; News and Statistics"},"content":{"rendered":"<p>\n\t\t\t\t\t\t\t\t\t\t\t\tMay 10, 2026\t\t\t\t\t<\/p>\n<p><a href=\"https:\/\/app.indexbox.io\/companies\/profile\/721440\/\" target=\"_blank\" rel=\"noopener nofollow\">Novo Nordisk<\/a> CEO Mike Doustdar discussed the company&#8217;s collaboration with <a href=\"https:\/\/app.indexbox.io\/companies\/profile\/742175\/\" target=\"_blank\" rel=\"noopener nofollow\">Amazon<\/a> and the expanded availability of its weight-loss drugs in an interview on The Claman Countdown. The oral versions of the company&#8217;s blockbuster treatments, <a href=\"https:\/\/app.indexbox.io\/indicators\/symbol\/novo-nordisk-a-s\/\" target=\"_blank\" rel=\"noopener nofollow\">Ozempic<\/a> and <a href=\"https:\/\/app.indexbox.io\/indicators\/symbol\/novo-nordisk-a-s\/\" target=\"_blank\" rel=\"noopener nofollow\">Wegovy<\/a>, are now offered for same-day delivery through Amazon.<\/p>\n<p>According to Doustdar, the once-daily pill formulations have achieved significant commercial success. The Ozempic pill was introduced last week, following the January launch of the oral version of Wegovy, which generated over $350 million in first-quarter sales. Doustdar noted that more than one million patients have tried the Wegovy pill within 16 weeks of its launch, describing it as the best product launch in the last decade.<\/p>\n<p>Ozempic is prescribed for patients with Type 2 Diabetes, while Wegovy is used to treat obesity. Both medications were originally developed as weekly injectables, but the newer versions are taken as a once-daily pill. Doustdar indicated that the Wegovy pill is expected to be the flagship product, though the Ozempic pill, leveraging its well-known brand, will also secure a strong market position.<\/p>\n<p>Novo Nordisk was among the first companies to collaborate with the Trump administration to reduce prescription drug costs. Doustdar emphasized that lowering prices is crucial for ensuring fair access, stating that while reduced prices have increased patient volume and harmed short-term business, it is the right long-term approach.<\/p>\n<p>Beyond weight loss, Doustdar highlighted the drugs&#8217; broader health benefits, including positive effects on cardiovascular, kidney, and liver health, particularly their ability to address scarring in patients with fatty liver disease.<\/p>\n<p>\t\t1. INTRODUCTION<\/p>\n<p class=\"text-secondary fs-6\">Making Data-Driven Decisions to Grow Your Business<\/p>\n<p>\t\t\t\tREPORT DESCRIPTION<br \/>\n\t\t\t\tRESEARCH METHODOLOGY AND THE AI PLATFORM<br \/>\n\t\t\t\tDATA-DRIVEN DECISIONS FOR YOUR BUSINESS<br \/>\n\t\t\t\tGLOSSARY AND SPECIFIC TERMS<\/p>\n<p>\t\t2. EXECUTIVE SUMMARY<\/p>\n<p class=\"text-secondary fs-6\">A Quick Overview of Market Performance<\/p>\n<p>\t\t\t\tKEY FINDINGS<br \/>\n\t\t\t\tMARKET TRENDS <a class=\"px-2\" href=\"https:\/\/www.indexbox.io\/licenses\/\" target=\"_blank\" rel=\"nofollow noopener\">This Chapter is Available Only for the Professional Edition<\/a>PRO<\/p>\n<p>\t\t3. MARKET OVERVIEW<\/p>\n<p class=\"text-secondary fs-6\">Understanding the Current State of The Market and its Prospects<\/p>\n<p>\t\t\t\tMARKET SIZE: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tCONSUMPTION BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tMARKET FORECAST TO 2035<\/p>\n<p>\t\t4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION<\/p>\n<p class=\"text-secondary fs-6\">Finding New Products to Diversify Your Business<\/p>\n<p>\t\t\t\tTOP PRODUCTS TO DIVERSIFY YOUR BUSINESS<br \/>\n\t\t\t\tBEST-SELLING PRODUCTS<br \/>\n\t\t\t\tMOST CONSUMED PRODUCTS<br \/>\n\t\t\t\tMOST TRADED PRODUCTS<br \/>\n\t\t\t\tMOST PROFITABLE PRODUCTS FOR EXPORT<\/p>\n<p>\t\t5. MOST PROMISING SUPPLYING COUNTRIES<\/p>\n<p class=\"text-secondary fs-6\">Choosing the Best Countries to Establish Your Sustainable Supply Chain<\/p>\n<p>\t\t\t\tTOP COUNTRIES TO SOURCE YOUR PRODUCT<br \/>\n\t\t\t\tTOP PRODUCING COUNTRIES<br \/>\n\t\t\t\tTOP EXPORTING COUNTRIES<br \/>\n\t\t\t\tLOW-COST EXPORTING COUNTRIES<\/p>\n<p>\t\t6. MOST PROMISING OVERSEAS MARKETS<\/p>\n<p class=\"text-secondary fs-6\">Choosing the Best Countries to Boost Your Export<\/p>\n<p>\t\t\t\tTOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT<br \/>\n\t\t\t\tTOP CONSUMING MARKETS<br \/>\n\t\t\t\tUNSATURATED MARKETS<br \/>\n\t\t\t\tTOP IMPORTING MARKETS<br \/>\n\t\t\t\tMOST PROFITABLE MARKETS<\/p>\n<p>\t\t7. PRODUCTION<\/p>\n<p class=\"text-secondary fs-6\">The Latest Trends and Insights into The Industry<\/p>\n<p>\t\t\t\tPRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tPRODUCTION BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t8. IMPORTS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Import Supplying Countries<\/p>\n<p>\t\t\t\tIMPORTS: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tIMPORTS BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tIMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t9. EXPORTS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Destinations for Exports<\/p>\n<p>\t\t\t\tEXPORTS: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tEXPORTS BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tEXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t10. PROFILES OF MAJOR PRODUCERS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Producers on The Market and Their Profiles<\/p>\n<p>                        11. COUNTRY PROFILES<\/p>\n<p class=\"text-secondary fs-6\">The Largest Markets And Their Profiles<\/p>\n<p>                        <a class=\"pe-2 fs-5 mb-2\" target=\"_blank\" href=\"https:\/\/www.indexbox.io\/licenses\/\" rel=\"nofollow noopener\">This Chapter is Available Only for the Professional Edition<\/a><br \/>\n                        PRO<\/p>\n<p>11.1<\/p>\n<p>United States<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.2<\/p>\n<p>China<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.3<\/p>\n<p>Japan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.4<\/p>\n<p>Germany<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.5<\/p>\n<p>United Kingdom<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.6<\/p>\n<p>France<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.7<\/p>\n<p>Brazil<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.8<\/p>\n<p>Italy<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.9<\/p>\n<p>Russian Federation<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.10<\/p>\n<p>India<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.11<\/p>\n<p>Canada<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.12<\/p>\n<p>Australia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.13<\/p>\n<p>Republic of Korea<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.14<\/p>\n<p>Spain<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.15<\/p>\n<p>Mexico<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.16<\/p>\n<p>Indonesia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.17<\/p>\n<p>Netherlands<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.18<\/p>\n<p>Turkey<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.19<\/p>\n<p>Saudi Arabia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.20<\/p>\n<p>Switzerland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.21<\/p>\n<p>Sweden<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.22<\/p>\n<p>Nigeria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.23<\/p>\n<p>Poland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.24<\/p>\n<p>Belgium<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.25<\/p>\n<p>Argentina<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.26<\/p>\n<p>Norway<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.27<\/p>\n<p>Austria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.28<\/p>\n<p>Thailand<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.29<\/p>\n<p>United Arab Emirates<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.30<\/p>\n<p>Colombia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.31<\/p>\n<p>Denmark<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.32<\/p>\n<p>South Africa<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.33<\/p>\n<p>Malaysia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.34<\/p>\n<p>Israel<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.35<\/p>\n<p>Singapore<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.36<\/p>\n<p>Egypt<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.37<\/p>\n<p>Philippines<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.38<\/p>\n<p>Finland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.39<\/p>\n<p>Chile<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.40<\/p>\n<p>Ireland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.41<\/p>\n<p>Pakistan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.42<\/p>\n<p>Greece<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.43<\/p>\n<p>Portugal<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.44<\/p>\n<p>Kazakhstan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.45<\/p>\n<p>Algeria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.46<\/p>\n<p>Czech Republic<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.47<\/p>\n<p>Qatar<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.48<\/p>\n<p>Peru<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.49<\/p>\n<p>Romania<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.50<\/p>\n<p>Vietnam<\/p>\n<p>Market SizeProductionImportsExports<br \/>\n\t\tLIST OF TABLES<\/p>\n<p>\t\t\t\tKey Findings In 2025<br \/>\n\t\t\t\tMarket Volume, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tMarket Value: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tPer Capita Consumption, by Country, 2022\u20132025<br \/>\n\t\t\t\tProduction, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<\/p>\n<p>\t\tLIST OF FIGURES<\/p>\n<p>\t\t\t\tMarket Volume, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tMarket Value: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tConsumption, by Country, 2025<br \/>\n\t\t\t\tMarket Volume Forecast to 2035<br \/>\n\t\t\t\tMarket Value Forecast to 2035<br \/>\n\t\t\t\tMarket Size and Growth, By Product<br \/>\n\t\t\t\tAverage Per Capita Consumption, By Product<br \/>\n\t\t\t\tExports and Growth, By Product<br \/>\n\t\t\t\tExport Prices and Growth, By Product<br \/>\n\t\t\t\tProduction Volume and Growth<br \/>\n\t\t\t\tExports and Growth<br \/>\n\t\t\t\tExport Prices and Growth<br \/>\n\t\t\t\tMarket Size and Growth<br \/>\n\t\t\t\tPer Capita Consumption<br \/>\n\t\t\t\tImports and Growth<br \/>\n\t\t\t\tImport Prices<br \/>\n\t\t\t\tProduction, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tProduction, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tProduction, by Country, 2025<br \/>\n\t\t\t\tProduction, In Physical Terms, by Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms, By Country, 2025<br \/>\n\t\t\t\tImports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms, By Country, 2025<br \/>\n\t\t\t\tExports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<\/p>\n","protected":false},"excerpt":{"rendered":"May 10, 2026 Novo Nordisk CEO Mike Doustdar discussed the company&#8217;s collaboration with Amazon and the expanded availability&hellip;\n","protected":false},"author":2,"featured_media":79215,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[274,25814,2832,272,5381,25815,3102,25816,2142,1910],"class_list":{"0":"post-79214","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-amazon","9":"tag-levemir","10":"tag-mike-doustdar","11":"tag-novo-nordisk","12":"tag-novo-nordisk-foundation","13":"tag-novolog","14":"tag-ozempic","15":"tag-saxenda","16":"tag-type-2-diabetes","17":"tag-wegovy"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116551177071015500","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/79214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=79214"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/79214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/79215"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=79214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=79214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=79214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}